Under 40€ another tranche at $ADM (-2,51%) add another tranche. Are somehow already systemically relevant

Archer Daniels
Price
Discussione su ADM
Messaggi
53Review of February 2025
The second month of 2025 is already over. Time is flying by again at breakneck speed and one event or statement follows the next this year. It's crazy what's going on at the moment and at the same time the market is somehow saying "I don't care".
Up down, up down, the markets are becoming more volatile and yet, or precisely because of this, my February was almost at +/-0.
But one thing at a time.
In February I achieved a plus of 0.8%. With my portfolio size, this corresponds to a value of almost €900. Not particularly good compared to the Dax (+3.77%), but still very respectable compared to the HSBC MSCI World (-2.49%).
Unfortunately, things do not look any better over the year (YTD).
The Dax is running away with 13.3%, while the MSCI World is bobbing along at 1.6%. Here, too, I was at least able to beat the World, but I still lag miles behind the DAX.
Overall, however, I am still very satisfied. As I don't have a lot of tech in my portfolio and my stocks are (mostly) rather stable, there is often no outperformance of the stocks and if there is, it is only marginal.
My high and low performers in February were (top 3):
$HSY (+0,24%) Hershey +15.63%
$T (-0,36%) AT&T +14.07%
$NESN (+2,09%) Nestle +13.10%
$ADM (-2,51%) Archer Daniels -8.57%
$UNH (+0,65%) United Health -13.16%
$TSLA (-3,59%) Tesla -27.59%
Dividends:
In February, I received a net €123.62 from a total of 10 distributions.
Compared to February 2024 (€99.26), this was an increase of 24.54%
Investments:
Due to the construction work on the house last year, the focus continues to be on building up the nest egg and saving up a "leisure account" again, as everything was really used up completely last year and only the custody account remained.
The savings plans will of course continue unabated, but individual investments are probably not possible for the time being.
Purchases and sales:
I have parted with Mercedes ( $MBG (-2,59%) ) and Medical Properties ( $MPW (-3,83%) ).
I then added to Lockheed Martin ( $LMT (+0,01%) ), Hershey ( $HSY (+0,24%) ) and Petroleo Brasileiro ( $PETR4 (-2,47%) ).
My savings plans remain unchanged, but it is quite possible that I will stop them for the time being in order to build up investment cash again.
Savings plans (350€ in total):
- Realty ($O (-1,43%) )
- STAG Industrial ($STAG (-7,16%) )
- Gladstone Invest ($GAIN (-4,13%) )
- Hercules Capital ($HTGC (-4,91%) )
- Cintas ($CTAS (-3,49%) )
- LVMH ($MC (-4,43%) )
- Monster Beverage ($MNST (-1,22%) )
- Microsoft ($MSFT (-2,62%) )
Goals 2025:
My goal is to have €130,000 in my portfolio at the end of the year. The goal is to be achieved by reinvesting the dividend, making payments and, of course, increasing the share price. The share price increase is of course impossible to predict in any way, so the motto is: if the share price falls or does not rise enough, more cash is needed.
This comes from selling useless stuff on eBay, additional income from e.g. "neighborhood help" etc. The worse the share price, the more additional cash has to be raised.
Target achievement at the end of February 2025: 37.41%
So I'm on the right track (so far). I'm curious to see what else will happen in 2025 and hope that the crash, which seems to be getting closer and closer, will take a little longer (so that I can continue to accumulate cash).
How was your February? Are you happy so far? I think that, due to the volatility, the portfolios in February are far more spread out than they were in January or even at the end of last year.


I invested in the agri-food sector!
I decided to close my position in the Chinese tech company $BABA (+1,12%) with a 2x return to enter in a new sector and diversify my portfolio.
I chose to invest in Archer Daniels Midland Company ($ADM (-2,51%) ), one of the largest companies in the global agricultural sector, specializing in the processing of agricultural commodities and the production of ingredients for food, beverages, and animal feed.
ADMs shares exhibit the typical cyclical behavior of the agricultural sector, heavily influenced by fluctuations in commodity prices and global demand for food and biofuels. After a period of exuberance, during which stock prices reached high peaks due to increased demand and certain conjunctural factors, the price adjusted to a more justified level, reflecting the actual market conditions.
This decline represents a healthy correction and positions ADM as an attractive investment opportunity, given its solid growth history and its ability to innovate and adapt to global trends. Therefore, considering the long-term appreciation potential and the risk/reward profile, investing in ADM can prove to be a strategic decision.
With this investment, the #portfolio becomes more diverse and has a more defensive and less volatile exposure.
ArcherDanielsMidland Q4 FY24 EarningsReport Summary
💼 Performance Overview:
ADM reported a 6.43% YoY decline in revenue to $21.50B, reflecting softer market conditions and biofuel policy uncertainty. Net income remained stable at $567M (+0.35% YoY), while adjusted EPS fell 16% to $1.14 due to lower segment profitability. The company maintained a 6.23% operating margin, despite higher costs and lower commodity prices.
📊 Key Financial Metrics (YoY Growth):
▫️ Revenue: $21.50B vs. $22.98B (-6.43%)
▫️ Net Income: $567M vs. $565M (+0.35%)
▫️ Adj. EPS: $1.14 vs. $1.36 (-16%)
▫️ Gross Margin: 6.32% vs. 7.57% (-1.25 pp)
▫️ Operating Margin: 6.23% vs. 6.99% (-0.76 pp)
📍 Segment Breakdown:
▫️ Ag Services & Oilseeds: $644M (-32%) — Lower crush margins due to higher manufacturing costs and increased industry supply.
▫️ Carbohydrate Solutions: $319M (+3%) — Higher ethanol export volumes, offset by lower co-product values in EMEA.
▫️ Nutrition: $88M (vs. -$10M) — Strong recovery in Human Nutrition, supported by higher volumes and improved mix.
💰 Balance Sheet Highlights:
▫️ Cash & Equivalents: $611M vs. $1.37B (-55%)
▫️ Total Assets: $35.91B vs. $36.08B (-0.46%)
▫️ Debt: $10.16B vs. $8.37B (+21.4%)
▫️ Operating Cash Flow: $2.78B vs. $4.46B (-37.7%)
📈 Future Outlook:
▫️ 2025 Adjusted EPS Guidance: $4.00 - $4.75
▫️ Strategic Priorities: Cost savings of $500M-$750M, focused on manufacturing efficiency, supply chain optimization, and workforce reduction (~600-700 roles).
▫️ Dividend Increase: Raised by 2% to $0.51/share (93rd consecutive year of dividend payments).
🔎 Key Takeaway: ADM is prioritizing cost efficiency and cash flow management amid a challenging macroeconomic environment, while maintaining a disciplined capital allocation strategy.
Trump's new tariffs, rising inflation and a trade war on the horizon?
In the following post, I would like to discuss the new US tariffs and their potential economic consequences. The background and the potential impact on inflation and companies, as well as the winners and losers on the stock market, will be discussed.
Again, of course, the stocks mentioned do not constitute investment advice, but merely serve as examples of possible beneficiaries or losers of tightening trade restrictions. Historical developments are no guarantee of future returns.
__________
In this post:
- Influence on inflation
- New tariffs in force
- Reaction of the countries
- Consequences for the global economy
- Winners & losers
- Investment opportunities
__________
The topic of "tariffs" is currently not only very present in the media, but the term "tariffs" has also been discussed with a strong increase in the past earnings calls of companies in the S&P 500, as the following chart shows [1].
The chart shows that the discussion about tariffs has intensified in recent months and is having an ever greater impact on the outlook in companies' annual reports.
The data is presented as a three-month average and broken down into various sectors, including e.g. industry, healthcare, consumer goods, information technology, etc.
I am curious to see how the stock markets will behave in the coming week. In addition to the current reporting season, the topic of "tariffs" will certainly dominate.
After the tough tariffs announced after Trump took office were not immediately enforced and there was a "slight" sigh of relief, there could now be a new reaction on the markets, as there was on Friday evening. slightly was already slightly noticeable on Friday evening when the markets turned towards the evening.
A looming trade conflict could not only affect individual companies, but also further fuel inflation in the US:
💰 Influence on inflation
On January 31, Deutsche Bank published a forecast on the potential impact of tariffs on the inflation rate [2]:
The chart compares the current forecast with the forecast before the "Trump" era and takes into account various scenarios for the passing on of tariffs (pass-through) by Canada and Mexico.
Two scenarios are considered: one with a 50% pass-through of tariffs (additional increase shown in dark green) and one with a 75% pass-through (light green). It is clear that the inflation rate could rise sharply again this year and fall again by 2027.
🛃 New tariffs in force & further measures planned
As of today, February 1, 2025, the US government and Donald Trump have imposed new import tariffs on Mexico, Canada and China:
- 25% on imports from Mexico and Canada
- 10% on imports from China
According to the White House spokesperson, these measures are, among other things, a response to the failure of these countries to stop the influx of fentanyl and illegal immigrants into the USA. [3]
But this is just the beginning:
From mid-February, the USA will also impose tariffs on strategic goods [4], including:
- computer chips
- pharmaceuticals
- Steel, aluminum and copper
- Oil and gas imports (but only from February 18 with reduced 10% tariffs so as not to burden US petrol prices immediately).
🚨 Trump relies on escalation - Canada announces retaliation
Yesterday, Canadian government representatives, including Foreign Minister Mélanie Joly, tried to prevent the tariffs in Washington, but to no avail.
Trump made it clear before his departure to Mar-a-Lago [5]:
"We have a 200 billion dollar trade deficit with Canada. Why should we subsidize Canada?"
The EU could also soon be targeted, as Trump hinted:
"Absolutely! The European Union has treated us so terribly!"
🔄 Canada's reaction:
Prime Minister Justin Trudeau announced that Canada will not back down and will respond with "swift and robust countermeasures".
The government is planning a three-stage retaliation strategy [5]:
- 1️⃣ Targeted punitive tariffs on US products coming from Republican states (e.g. orange juice, whiskey, ketchup, peanut butter and motorcycles).
- 2️⃣ Tariffs on steel products and machine parts from the USA.
- 3️⃣ Escalation: Stop exports of oil, gas and electricity to the USA
However, this last step in particular would be a double-edged sword, as Canada is heavily dependent on energy cooperation with the USA.
Economic experts in the US are already warning of the consequences of a trade war [5]:
- The new tariffs could increase the cost of living of an average US household by 800 dollars per year.
- The oil and gas tariffs could increase the price of petrol in the USA by up to 20 cents per liter.
But Trump remains firm:
"Maybe there will be short-term disruption, but in the long run the tariffs will make us very rich and very strong."
🌎 Possible consequences for the global economy
(a) Rising prices in the USA
- Technology & electronicsHigher chip prices are hitting companies such as Apple $AAPL (-6,25%) , Dell $DELL and HP $HPQ (-14,31%) as many of their components come from China.
- Healthcare costs: Pharmaceutical companies such as CVS Health $CVS (+0%) and Walgreens Boots Alliance $WBA (+0%) are facing higher purchasing costs.
- Construction & InfrastructureHigher steel prices are weighing on companies such as Lennar $LEN (-7,94%) D.R. Horton $DHI (-4,46%) and Caterpillar $CAT (-7,99%) .
(b) Retaliation & new trade wars?
- China could impose tariffs on US products, which could affect e.g. Archer Daniels Midland $ADM (-2,51%) Boeing $BA (-10,13%) and Qualcomm $QCOM (-8,69%) would be affected.
- The EU could make US imports more expensive, which would affect Tesla $TSLA (-3,59%) , Ford $F (-6,67%) and General Motors $GM (-2,99%) could be harmed.
(c) Effects on the stock market
- Volatility is increasing as there is uncertainty about the consequences for various industries.
- Particularly affected: Technology and automotive stocks with global supply chains.
🏆 Winners & losers - which companies will benefit, which will suffer?
Possible beneficiaries of the tariffs
US manufacturers of steel, aluminum & copper
- Nucor $NUE (-9,99%) , U.S. Steel $X (+0%) and Freeport-McMoRan $FCX (-12,35%) could benefit as foreign competition becomes more expensive as a result of the tariffs.
Domestic pharmaceutical and biotech companies
- Pfizer $PFE (-2,63%) Moderna $MRNA (-6,62%) and Eli Lilly $LLY (-3,56%) could gain market share.
Energy companies with US production
- ExxonMobil $XOM (-5,48%) , Chevron$CVX (-6,89%) and Expand Energy $CHK (-4,56%) could benefit from rising prices for US oil and gas.
Chip manufacturers with US production
- Intel $INTC (+2,5%) and Texas Instruments$TXN (-8,2%) have US factories and could gain market share.
😥 Companies that could suffer from the tariffs
Chip manufacturers with global supply chains
- Apple $AAPL (-6,25%) NVIDIA $NVDA (-6,05%) , AMD $AMD (-7,86%) are dependent on Asian imports and could see higher production costs.
Car manufacturers with global suppliers
- Tesla $TSLA (-3,59%) , Ford $F (-6,67%) , General Motors $GM (-2,99%) are under pressure because components from Mexico and Canada could become more expensive.
Companies with strong export business
- Boeing $BA (-10,13%) and Caterpillar $CAT (-7,99%) suffer from possible retaliatory tariffs.
US retailers with a high import share
- Walmart $WMT (-1,54%) , Target $TGT (-8,31%) and Nike $NKE (-9,93%) could have to pass on rising prices to customers.
🧠 Possible investment strategies
Favor defensive sectors:
- Utilities (e.g. NextEra Energy $NEE (+0,71%) Duke Energy $DUK (+1,43%) ) and healthcare companies (e.g. UnitedHealth $UNH (+0,65%) , Johnson & Johnson $JNJ (+1,02%) ) remain more stable.
Exploit long-term opportunities in "reshoring":
- Intel $INTC (+2,5%) , Eli Lilly $LLY (-3,56%) , Nucor $NUE (-9,99%) could benefit in the long term.
Conclusion: Will the trade conflict escalate further?
With the new tariffs, Trump is taking a confrontational stance and Canada, Mexico and China are preparing for retaliatory measures. If further tariffs on European goods follow, the situation could worsen.
❓Which stocks do you think could be most affected? Which beneficiaries do you see?
Thanks for reading! 🤝
__________
Sources:
[4]
[5] https://www.tagesschau.de/ausland/amerika/usa-trump-strafzoelle-100.html


My Rewind 2024 - Getquin wrapped
Preface:
In the following, I would like to present how my portfolio has developed over the course of 2024.
This includes
1) my strategic orientation
2)Return on the portfolio.
The main topics are:
- Moving away from individual stocks
- Entry into gold and bitcoin
- Factor investing
Finally, I will give my own thoughts on how to proceed.
The main changes to my portfolio that have led
to my current strategy are presented below using a short timeline.
timeline:
My timeline
Beginning of 2024
At the beginning of the year, I pursued a 70/30 core satellite
strategy. The 70% ETF core again consisted of STOXX Europe.
MSCI World, Emerging Markets.
The 30% consisted of stocks such as: $CSIQ (-5,97%) , $O (-1,43%) ,$TSM (-4,48%)
$ADM (-2,51%)
$UMI (-6,37%)
$D05 (-3,04%)
$BMW (-2,73%)
$UKW (-2,3%)
$8031 (-3,7%)
$MUV2 (+0,75%)
February
Addition of gold to my portfolio. Target size 10%. Build-up in batches.
The remaining 70/30 strategy therefore only relates to the remaining
90%.
April-June:
Entry into Bitcoin via Trade Republic in several batches
at prices between 50k and 63k.
After exchange with @Epi to the fee schedule at Trade Republic
I sold them there in order to sell Bitcoin on a dedicated crypto exchange.
exchange.
June:
Thanks to @PowerWordChill I got to grips with factor investing. A Gerd Kommer book later, and after some internet research, I decided to
decided to transform my ETF strategy into a factor ETF strategy.
July-August 2024:
Sale of my shares. Concentration on the factor portfolio.
August - September 24:
Renewed build-up of Bitcoin with the aim of making Bitcoin a
a fixed component of the portfolio. Consideration is 5%-10%
of my portfolio.
The idea. Build up an initial position, then make regular
investments of €50 per week with the aim of growing to the target size
to grow to the target size. The rapid rise in October/November led me to
led me to leave it at €50 per week. And individual purchases in
larger tranches at an early stage with a portfolio size of 2.x%.
End of December 2024:
Position size of Bitcoin almost 5%.
I am not yet including Bitcoin in my gold/ETF quota. I'm still running it on the side.
I re-evaluated my factor weighting at the end of the year
and would like to fine-tune it a little. I will briefly present the result in the
following section.
In addition, I have decided to include a small
include a small proportion of real estate stocks. However, this will probably never
part of my strategy worth mentioning and contains - as of today - only
about 3% of my portfolio and only $O (-1,43%) ).
Overall breakdown of my portfolio:
As described above, I do not yet include Bitcoin in my overall strategy
part of my overall strategy so that rebalancing remains easier. This will
change when Bitcoin reaches its target size.
The rest is made up as follows:
ETFs:
$XDEM (-4,85%) 30.3% (MSCI World Momentum)
$XDEB (-1,37%) 10.1% (MSCI World Minimum Volatility)
$XDEV (-4,05%) 10.1% (MSCI World Value)
$ZPRV (-5,97%) 15% (MSCI USA Small Cap Value Weighted)
$ZPRX (-2,41%) 6.5% (MSCI Europe Small Cap Value Weighted)
$PEH (-0,01%) 4.5% (as a quality factor on emerging markets)
$5MVL (-0,66%) 4.5% (Edge MSCI EM Value)
$SPYX (-0,07%) 9% (MSCI EM Small Cap)
Gold
$EWG2 (-2,33%) 10% Gold ETC
Getquin Rewind and own data:
At the end of the post you will find my Getquin Rewind, as I was not able to embed the image in the text:
However, according to my own calculations, this cannot be correct.
My portfolio volume at the start of the year was around €103,500 with a return of €16,693. This would correspond to a total return of 19.2%. However, we are not yet talking about a time-weighted return, as my invested capital has roughly doubled over the course of the year. I therefore estimate my TTWROR to be higher.
My own thoughts and outlook:
I do not expect any major changes in strategy over the next few years. At some point, a strategy will have to be established. If necessary, I will make some adjustments to this strategy.
This includes the fact that I am dissatisfied with the costs of the emerging markets factor ETFs. So far, however, I intend to live with it. Should I
stumble across better products, I will consider switching. Especially as long as I stay within the tax allowance when switching.
I'll also have to decide how big my Bitcoin holding should ultimately be.
If you've been reading carefully, you'll notice that a lot of money has accumulated in the last year. Big profits, big investments. Due to personal circumstances, I will not maintain these rates in the same style, but will reduce them somewhat. I expect to be able to continue investing around 1.5-2k per month. This means that my financial goals are
with an expected return of 5% adjusted for inflation over many years.
I am half hoping for major setbacks in the near future and the associated favorable entries. However, in view of the impact that minor price jolts have had on society as a whole (thanks to populism), I don't really wish for them.
Do you have any suggestions, questions or comments? Is there anything that particularly interests you?
I am also happy to receive suggestions for improvement for future posts.
Best regards,
Your Smurf
PS: @DonkeyInvestor and me, that's love ❤. And now send me your coins! (So I can reward your next post appropriately).
PPS: I hope someone is interested.

ADM Q3 2024 $ADM (-2,51%)
Financial performance:
Net profit: For the quarter ended September 30, 2024, net income was only $18 million, a significant decrease from $821 million in the same quarter last year.
Adjusted net income: Adjusted net income for the quarter was USD 530 million, compared to USD 880 million in the prior year.
Adjusted EPS: Adjusted earnings per share (EPS) were $1.09, compared to $1.63 in the prior year.
Balance sheet overview:
- Invested Capital: Total invested capital amounted to USD 32,025 million as at September 30, 2024.
Results of operations by segment:
Ag Services and Oilseeds: Operating profit fell to USD 480 million, a decrease of 43% compared to the previous year. The decline is due to lower results in South America and lower margins in refining and biodiesel production.
Carbohydrate Solutions: Operating profit was USD 452 million, a slight decrease of 3% compared to the previous year. However, the segment continued to benefit from a strong performance in starches and sweeteners.
Nutrition: Operating profit decreased 19% to $105 million, primarily due to higher costs and lower margins in human nutrition.
Cash flow overview:
- Operating cash flow: For the nine months ended September 30, 2024, operating cash flow was USD 2,468 million, an increase compared to USD 1,891 million in 2023.
- Cash flow before working capital: This amounted to USD 2,341 million for the nine months.
Key figures and profitability metrics:
- Adjusted return on invested capital (ROIC): The adjusted return on invested capital for the last four quarters to September 30, 2024 was 6.6%.
Segment information:
- Ag Services and Oilseeds: The decline in operating profit was impacted by lower results in South America and lower refining and biodiesel margins.
- Carbohydrate Solutions: The segment reported a solid performance in starches and sweeteners, but slightly lower profits.
- Nutrition: The segment reported declining profits due to higher costs and lower margins in human nutrition.
Competitive position:
The company faces challenges in maintaining margins due to increased competition and current market conditions, particularly in the Ag Services and Oilseeds segments.
Management forecasts and comments:
- EPS guidance: The company has lowered its full-year 2024 EPS guidance to a range of $4.50 to $5.00.
Risks and opportunities:
- Risks: The company is struggling with slowing market demand, internal operational challenges and uncertainties related to legal and regulatory frameworks.
- Opportunities: Despite the challenges, the company sees opportunities in the area of cost optimization as well as in strong sub-services such as animal nutrition.
Summary of results:
The company is experiencing a difficult financial year with significant declines in net profit and operating profits in all segments. The adjusted key figures show a slightly more positive picture, but also indicate a decline compared to the previous year. The company is adjusting its financial strategy and has lowered its EPS forecast for the year. While operational challenges and market conditions remain as key risks, strategic cost optimization and strengths in certain segments offer potential for future improvements.
Positive aspects:
Equity income from Wilmar investment: Equity earnings from the Wilmar investment increased to USD 62 million in the quarter, up from USD 35 million in the prior year quarter. This shows a positive development of this investment.
Animal Nutrition (sub-segment): The Animal Nutrition sub-segment recorded an operating profit of USD 19 million, an increase of 58 % compared to the same quarter last year. This improvement is due to cost optimization and lower input costs.
Starch & Sweetener segment: This segment reported a 13% increase in operating profit compared to the same period last year, supported by strong volumes and margins.
Cash flow from operating activities: Net cash flow from operating activities for the nine months ended September 30, 2024 was USD 2,468 million, an increase from USD 1,891 million in the prior year period, indicating improved cash generation.
Insurance proceeds: The company received significant insurance proceeds, including $47 million for Decatur West insurance claims and $25 million for Decatur East, which positively impacted financial results.
Negative aspects:
Decrease in net income: Net income for the quarter ended September 30, 2024 was only $18 million, a drastic decrease from $821 million in the same quarter last year.
Ag Services and Oilseeds segment: Operating profit for this segment was $480 million, a decrease of 43% compared to the same quarter last year, primarily due to weaker results in South America and reduced margins.
Nutrition Segment: Nutrition segment operating profit decreased 19% to $105 million due to higher costs and lower margins in human nutrition.
Reduction in EPS guidance: The company has lowered its full-year 2024 EPS guidance to a range of $4.50 to $5.00, reflecting ongoing challenges and uncertainties.
Operational challenges: The company is facing operational challenges, including slower market demand and internal issues impacting overall performance.

Archer Daniels Midland Co. | $ADM (-2,51%)
Q3 results were postponed due to more accounting errors + they lowered 2024 guidance to $4.50-$5.00 from its previous $5.25-$6.25
Dear getquin-Community,
after several months of listening in / reading on the sidelines on getquin, I would like to throw my portfolio on the plate for you to give me some feedback / roastings / advice. Everything is welcome ;-)
I do not want to drop the portfolio without sharing some (personal) thoughts from my side, please find below:
- Asset Allocation:
- Bit unsure about short-term effects (e.g. US election) therefore rather high #cash ratio
- Would like to have higher #etf-ratio compared to individual stocks, but I cannot "control" myself as I would like to. Listening to quite a few financial podcasts and my watchlist has expanded since then quite a lot
- Not a big fan of anything else than #stocks and #bonds. My basic principle is that the money has to "work" / create inherent returns. Therefore no #gold, no #bitcoin in my portfolio
- Investment "Style":
- Difficult to explain myself
- Naturally, I feel drawn to #contrarian approaches since I regard stock market to be far from "efficient", much more influenced by behavioral biases pushing stocks too high when everything seems to be going great and pushing stocks too low when #momentum is against them
- I am convinced that these exaggerations can be "exploited" if you have a strong gut and can stand 30-50% draw-backs
- Mindset / Character:
- Had some heavy draw-backs on my positions in the past which I regularly used to increase my positions in these stocks. Examples from the current portfolio include $VNA (+8,1%), $BATS (+3,96%), $BARC (-9,65%), $PYPL (-7,18%)
- I would describe myself as having a tendency towards over-confidence and I am bit afraid of not being able to let go of losers in my portfolio (examples from my current portfolio could be $VOW (-2,95%), $VALE3 (-2,36%), $ADM (-2,51%), $INTC (+2,5%))
- My general approach would be to "double down" to "prove the others in the market wrong". Which is childish I assume, because why should I have any edge compared to the overall market. My only (potential) edge - e.g. compared to institutional funds - would be that I have rather little difficulties sleeping well if positions are substantially down. So I assume I can stand long periods of draw-backs. But this also makes me prone for sticking with particular investments until eternity/insolvency ;-)
I am were much looking forward to your feedback / roastings on my portfolio.
Thank you very much in advance.
Have a great time investing!
Yours
Markus